reports
Titan Cement International S.A.: 1 director
A director at Titan Cement International S.A. sold after exercising options/sold 250,000 shares at 30.700EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the com...
Bumi Serpong Damai Tbk(Pt): 1 director
A director at Bumi Serpong Damai Tbk(Pt) bought 7,336,200 shares at 938.150IDR and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
HD Hyundai: 1 director
A director at HD Hyundai bought 82,500 shares at 67,003.509KRW and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
- Martin Marandon-Carlhian
- Stephane Houri
Arm Holdings plc : Arm remains the key vehicle to play the growing com...
>Outperform rating reiterated, target price increased to $ 130 (vs $ 110) - We did a recap with the company a few days after the release of its Q4 2023-24 results and came away with confirmation that Arm is set to continue to grow at an average of 20% per year over the next three years. Growth, as we wrote in our report initiating coverage of the stock, stems from an accelerated architecture complexification process, driven initially by the acceleration in significant...
Aktietilbagekøb i Sparekassen Sjælland-Fyn – transaktioner i uge 20
Aktietilbagekøb i Sparekassen Sjælland-Fyn – transaktioner i uge 20 Selskabsmeddelelse nr. 25/2024Holbæk, den 21. maj 2024 Aktietilbagekøb i Sparekassen Sjælland-Fyn – transaktioner i uge 20 Sparekassen Sjælland-Fyn A/S (”Sparekassen”) offentliggjorde den 13. maj 2024 et tilbagekøbsprogram på 100 mio. kr. Aktietilbagekøbsprogrammet startede den 13. maj 2024 og vil være afsluttet senest den 5. februar 2025. Aktietilbagekøbsprogrammet sker med henblik på nedsættelse af aktiekapitalen i Sparekassen og gennemføres efter bestemmelserne i Europa-Parlamentets og Rådets forordning (EU) nr. 596/...
- Marcel Schaffer
- Matthias Greiffenberger
GBC Research Management-Interview english – EasyMotionSkin Tec AG - 21...
EasyMotionSkin Tec AG and its subsidiary EasyMotionSkin Tec GmbH (Seefeld, Austria), (together the EasyMotionSkin Group) are active in the market for training and fitness equipment using electromuscular stimulation (EMS for short). The EasyMotionSkin Group has a wireless solution for EMS training devices using dry electrodes (EasyMotionSkin system). The dry electrode is a patented solution that cannot be used by competitors in this form. The companies of the EasyMotionSkin Group are active in th...
Heineken Silver is on a mission to end bitterness, starting with one o...
Heineken Silver is on a mission to end bitterness, starting with one of the biggest love-hate relationships in Marvel Studios’ “Deadpool & Wolverine” Heineken Silver Teams Up with “Deadpool & Wolverine” for New Summer Campaign WHITE PLAINS, N.Y., May 21, 2024 (GLOBE NEWSWIRE) -- Today the new world-class light beer, Heineken Silver, announced that they will once again be stepping into the Marvel Cinematic Universe (MCU), this time to celebrate the release of Marvel Studios’ “Deadpool & Wolverine”, in U.S. theaters July 26. The collaboration will include an exciting, new creative ca...
Atai Life Sciences NV: 1 director
A director at Atai Life Sciences NV sold 151,303 shares at 1.920USD and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Unisys Corp: 1 director
A director at Unisys Corp sold 78,868 shares at 5.075USD and the significance rating of the trade was 82/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
Intellicheck Inc: 1 director
A director at Intellicheck Inc bought 7,000 shares at 2.828USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
Ameriprise Financial Inc: 1 director
A director at Ameriprise Financial Inc sold 1,500 shares at 438.067USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
- Martin Marandon-Carlhian
- Stephane Houri
Arm Holdings plc : Arm reste le véhicule clé pour jouer la complexific...
>Opinion Surperformance réitérée, OC relevé à 130 $ (vs 110 $) - Nous avons fait le point avec la société, quelques jours après la publication du T4 23/24, et ressortons confortés sur le fait que Arm devrait continuer de croître en moyenne de 20% par an sur les 3 prochains exercices. Cette croissance découle bien, comme nous l’avions indiqué lors de notre initiation, d’un process accéléré de complexification des architectures, tirée dans un 1er temps par l’accélérati...
- Martin Marandon-Carlhian
- Stephane Houri
ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 05/21/2024
After a more challenging start to the year for Stellantis, we take a closer look at the stakes for the upcoming CMD (13/06) and our expectations as regards strategic levers that we see as still underestimated and the (significant) potential we continue to see for shareholder returns (close to 100%e of the current market cap by 2030 according to our estimates). We therefore believe it is interesting to return to the stock (TP increased to € 30) ahead of the CMD and the H1 results relea...
Medigene's Global Research & Collaboration Agreement with BioNTech to ...
Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term Planegg/Martinsried, May 21, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of differentiated T cell immunotherapies for solid tumors and BioNTech SE (Nasdaq: BNTX, “BioNTech”) have announced that their collaboration to advance T cell receptor (TCR) immunotherapies against cancer will extend beyond the initial three-year term outlined at the signing of the agreement in February 20...
Danske Bank share buy-back programme: Transactions in week 20
Danske Bank share buy-back programme: Transactions in week 20 Company announcement no. 21 2024 Group CommunicationsBernstorffsgade 40DK-1577 København VTel. 21 May 2024 Danske Bank share buy-back programme: Transactions in week 20 On 2 February 2024, Danske Bank A/S announced a share buy-back programme for a total of DKK 5.5 billion, with a maximum of 70 million shares, in the period from 5 February 2024 to 31 January 2025, at the latest, as described in company announcement no. 2 2024. The programme is being carried out under Regulation (EU) No. 596/2014 of the European Parliament and o...
UP Fintech Holding Limited to Report First Quarter 2024 Financial Resu...
UP Fintech Holding Limited to Report First Quarter 2024 Financial Results on June 5, 2024 SINGAPORE, May 21, 2024 (GLOBE NEWSWIRE) -- UP Fintech Holding Limited (“UP Fintech” or the “Company”) (NASDAQ: TIGR), a leading online brokerage firm focusing on global investors, today announced that it will report its financial results for the first quarter ended March 31, 2024, before the U.S. market opens on June 5, 2024. UP Fintech’s management will hold an earnings conference call at 8:00 AM on June 5, 2024, U.S. Eastern Time (8:00 PM on June 5, 2024, Singapore/Hong Kong Time). Conferenc...
- Roelof-Jan van den Akker
Technical Analysis/Bund future
Mixed signals in the weekly chart shows that we are still within the bottoming process. Prices exceeded the high of the week before last week at 131.86 by making a new high at 132.06. However, last week's close at 130.69 is disappointing as it ended 19bp lower and off the highs at 132.06. This suggests that confirmation of a bottom is still required and the focus should again be on support after this weakness. Solid support in the weekly chart between 129.85 and 129.10 with the April low at 129....
Moody's Ratings assigns Ba1 rating to EDP's hybrid instruments
Moody's Ratings (Moody's) has today assigned a Ba1 long-term rating to the proposed Fixed to Reset rate Subordinated Instruments (the junior subordinated "Hybrid") to be issued by EDP, S.A. ("EDP"). The size and completion of the Hybrid are subject to market conditions. The outlook is stable. RATI...
- Marcel Schaffer
- Matthias Greiffenberger
GBC Research Management-Interview – EasyMotionSkin Tec AG - 21.05.2024
Die EasyMotionSkin Tec AG und ihre Tochtergesellschaft die EasyMotionSkin Tec GmbH (Seefeld, Österreich), (gemeinsam die EasyMotionSkin-Gruppe) sind auf dem Markt der Trainings- und Fitnessgeräte unter Einsatz der Elektromuskelstimulation (kurz: EMS) tätig. Die EasyMotionSkin-Gruppe verfügt dabei über eine kabellose Lösung für EMS-Trainingsgeräte unter Einsatz von Trockenelektroden (EasyMotionSkin-System). Bei der Trockenelektrode handelt es sich um eine patentierte Lösung, die in dieser Form ni...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.